Literature DB >> 34602638

Prognostic role of lymphocyte to monocyte ratio in feline high-grade lymphomas.

Michihito Tagawa1, Genya Shimbo1, Kazuro Miyahara1.   

Abstract

The lymphocyte to monocyte ratio (LMR) is a useful prognostic marker of various cancers in human and canine patients. This study aimed to determine whether this ratio could predict disease outcomes in cats with high-grade lymphoma. Medical records of 33 cats diagnosed with high-grade lymphoma were retrospectively analyzed. The prognostic influence of LMR and other clinicopathological data on the time to progression (TTP) and overall survival (OS) was studied using the Kaplan-Meier curves. The optimal cutoff value of this ratio was 3.4, which corresponded to the maximum sensitivity (1.000) and specificity (0.611) of the LMR for predicting median OS days, using receiver operating characteristic analysis. A univariate analysis demonstrated that cats with a low LMR had significant reductions in both TTP [hazard ration (HR) = 3.403, 95% confidence interval (CI): 1.502 to 8.720; P = 0.003] and OS (HR = 3.418, 95% CI: 1.433 to 9.449, P = 0.005). In multivariate analysis, independent predictors of OS included LMR (HR = 2.889, 95% CI: 1.048 to 8.843, P = 0.040), clinical stage (HR = 0.330, 95% CI: 0.118 to 0.960, P = 0.042), and age (HR = 4.151, 95% CI: 1.574 to 11.888, P = 0.004). Copyright and/or publishing rights held by the Canadian Veterinary Medical Association.

Entities:  

Mesh:

Year:  2021        PMID: 34602638      PMCID: PMC8439333     

Source DB:  PubMed          Journal:  Can Vet J        ISSN: 0008-5286            Impact factor:   1.008


  36 in total

1.  Combination chemotherapy in feline lymphoma: treatment outcome, tolerability, and duration in 23 cats.

Authors:  D Simon; N Eberle; L Laacke-Singer; I Nolte
Journal:  J Vet Intern Med       Date:  2008-02-29       Impact factor: 3.333

2.  CD4(+) tumor infiltrating lymphocytes are prognostic and independent of R-IPI in patients with DLBCL receiving R-CHOP chemo-immunotherapy.

Authors:  Colm Keane; Devinder Gill; Frank Vari; Donna Cross; Lynn Griffiths; Maher Gandhi
Journal:  Am J Hematol       Date:  2013-03-05       Impact factor: 10.047

3.  Predictors of long-term survival in dogs with high-grade multicentric lymphoma.

Authors:  Laura Marconato; Damiano Stefanello; Paola Valenti; Ugo Bonfanti; Stefano Comazzi; Paola Roccabianca; Mario Caniatti; Giorgio Romanelli; Federico Massari; Eric Zini
Journal:  J Am Vet Med Assoc       Date:  2011-02-15       Impact factor: 1.936

4.  Retrospective analysis of factors affecting clinical outcome following CHOP-based chemotherapy in dogs with primary nodal diffuse large B-cell lymphoma.

Authors:  M O Childress; J A Ramos-Vara; A Ruple
Journal:  Vet Comp Oncol       Date:  2017-11-20       Impact factor: 2.613

5.  Feline lymphoma (145 cases): proliferation indices, cluster of differentiation 3 immunoreactivity, and their association with prognosis in 90 cats.

Authors:  D M Vail; A S Moore; G K Ogilvie; L M Volk
Journal:  J Vet Intern Med       Date:  1998 Sep-Oct       Impact factor: 3.333

6.  Lymphocyte-to-monocyte ratio is associated with survival in pembrolizumab-treated metastatic melanoma patients.

Authors:  Jarrett J Failing; Yiyi Yan; Luis F Porrata; Svetomir N Markovic
Journal:  Melanoma Res       Date:  2017-12       Impact factor: 3.599

7.  Efficacy of combination chemotherapy for treatment of gastrointestinal lymphoma in dogs.

Authors:  K M Rassnick; A S Moore; K E Collister; N C Northrup; O Kristal; J D Chretin; D B Bailey
Journal:  J Vet Intern Med       Date:  2009-02-02       Impact factor: 3.333

8.  Prognostic factors for treatment of malignant lymphoma in dogs.

Authors:  E Teske; P van Heerde; G R Rutteman; I D Kurzman; P F Moore; E G MacEwen
Journal:  J Am Vet Med Assoc       Date:  1994-12-15       Impact factor: 1.936

Review 9.  Clinical significance of tumor-infiltrating lymphocytes in breast cancer.

Authors:  Sasha E Stanton; Mary L Disis
Journal:  J Immunother Cancer       Date:  2016-10-18       Impact factor: 13.751

10.  Diagnosis, prognosis and treatment of primary central nervous system lymphoma in the elderly population (Review).

Authors:  Yanxia Liu; Qingmin Yao; Feng Zhang
Journal:  Int J Oncol       Date:  2021-02-01       Impact factor: 5.650

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.